Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Component Te-g Implants 40 mg Implant is a Health Canada–registered veterinary drug (DIN 02427486) held by Elanco Canada Limited, containing Trenbolone Acetate. Health Canada lists its status as Dormant (status date 23 Jul 2018). Nexara Health has matched 3 registrations of Trenbolone Acetate across 1 other regulated market.

Health Canada registration

DIN02427486
Brand nameComponent Te-g Implants
Active ingredientTrenbolone Acetate
Strength40 mg
Dosage formImplant
RouteSubcutaneous
CompanyElanco Canada Limited
StatusDormant — 23 Jul 2018
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Trenbolone Acetate registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesTrenbolone acetateValdepharmPowderFDA NDC
United StatesTrenbolone AcetatePharmacia and Upjohn Company LLCPowderFDA NDC
United StatesTrenbolone AcetateLaurus Synthesis Pvt LtdPowderFDA NDC

See every manufacturer of Trenbolone Acetate worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Component Te-g Implants (DIN 02427486) marketed in Canada?

No. Health Canada lists DIN 02427486 as Dormant as of 23 Jul 2018.

Who holds the Canadian licence for this product?

Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.

Is Trenbolone Acetate registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02427486, status date 2018-07-23; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02427486, status date 2018-07-23; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02427486, status date 2018-07-23; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.